|
CHECK OUT OUR DECEMBER 15TH ISSUE
Pharmacologic treatments for retina diseases continued to made headlines in 2013, including the release of ocriplasmin and the AREDS2 Study. » Read more
|
|
Experts discuss the growing market of MIGS, as well as their benefits and possible concerns, while examining alternative non-invasive intervention methods. » Read more
|
|
New products and medications for surgery became available in 2013, while a heavy eye remained concentrated on the cost of generics. » Read more
|
|
Approach ectasia using the 5S classification system to break down the condition into manageable components as part of a plan toward best vision potential. » Read more
|
|
Advancements in retina surgery include small-gauge instrumentation, a small vitrectomy machine, and a surgical microscope with optical coherence tomography. » Read more
|
|
Refinements in the design of the Refocus Scleral Implants (Refocus Group) to treat presbyopia (and glaucoma) and in the surgical implantation technique have improved markedly over the year, making the devices easier to implant and the surgery shorter. » Read more
|
|
|
Like
Tweet
